Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sublingual immunotherapy.

Giovanni Passalacqua1, Laura Guerra Enrico Compalati, Mercedes Pasquali

  • 1Department of Internal Medicine, University of Genoa, Italy. passalacqua@unige.it

Revista Alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)
|February 19, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

What is new on the horizon for the biologics world: New kids of the block - WAO state of art.

The World Allergy Organization journal·2026
Same author

A Link Between Allergy and Hematological Malignancies? Focus on Possible Mechanisms and the Potential Role of Biological Therapies.

Clinical and translational allergy·2026
Same author

Longitudinal observation of severe asthma comorbidities and oral corticosteroids use from SANI and ISAR registries.

The World Allergy Organization journal·2026
Same author

Former smokers with severe eosinophilic asthma respond to benralizumab as effectively as never-smokers: a <i>post hoc</i> analysis of the ANANKE study.

ERJ open research·2026
Same author

Multimorbidity phenotypes and associated characteristics in severe asthma: an observational study of European severe asthma registries.

The Lancet regional health. Europe·2026
Same author

Asthma Awareness Questionnaire: Development, Psychometric Validation, and Extent.

Pulmonary therapy·2026
Same journal

[Importance of early detection and prevention of secondary immunodeficiency in children with HIV].

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)·2026
Same journal

Rethinking tuberculosis: Microbiological and immunological crossroads in the post-pandemic era.

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)·2026
Same journal

[Symmetrical flexural and intertriginous rash related to corticosteroids].

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)·2026
Same journal

[Consensus of Mexican experts on long-term prophylaxis in patients with hereditary angioedema in Mexico].

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)·2026
Same journal

[Hypersensitivity to iodinated contrast media: Diagnostic and therapeutic strategies. Position Statement of the Drug Allergy Committee of the Mexican College of Clinical Immunology and Allergy].

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)·2026
Same journal

[Analysis of scientific production on asthma - COPD overlap syndrome].

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)·2026
See all related articles

Sublingual immunotherapy (SLIT) is a safe and effective treatment for respiratory allergies in children and adults. Accepted by the WHO, SLIT offers a promising alternative to traditional allergy management strategies.

Area of Science:

  • Immunology
  • Allergy Management
  • Pharmacology

Background:

  • Allergen-specific immunotherapy is a key component of respiratory allergy management.
  • Sublingual immunotherapy (SLIT) has emerged as a promising approach due to its safety profile.
  • The World Health Organization (WHO) officially recognized SLIT as a clinical option.

Purpose of the Study:

  • To review current clinical efficacy of sublingual immunotherapy.
  • To assess the safety profile of sublingual immunotherapy.
  • To examine the pharmacokinetics of sublingual immunotherapy.

Main Methods:

  • Review of clinical trials and scientific literature on SLIT.
  • Analysis of efficacy data in adult and pediatric populations.
  • Evaluation of safety and pharmacokinetic studies.

Related Experiment Videos

Main Results:

  • SLIT demonstrates significant clinical efficacy in managing respiratory allergies.
  • SLIT is associated with an optimal safety profile.
  • Pharmacokinetic data supports the effectiveness of SLIT.

Conclusions:

  • Sublingual immunotherapy is a well-established and effective treatment for respiratory allergies.
  • SLIT offers a safe and routine clinical option for both children and adults.
  • Further research continues to refine understanding of SLIT's mechanisms and applications.